F · FORD MOTOR CO
10-Q filed 2026-04-30 period 2026-03-31
60 Stable
confidence medium · source filing on SEC.gov ↗
- Ford is rationalizing its EV roadmap, cancelling three planned EVs and ending F-150 Lightning production, which could result in up to $4 billion in pre-tax charges.
- The company entered into a Joint Venture Disposition Agreement to redeem its interest in BlueOval SK (BOSK), expecting $3.5 billion in pre-tax charges, including $500 million in cash.
- Ford faces outstanding Brazilian tax assessments that could require posting collateral in excess of $1 billion, though management considers the risk of loss remote.
Filing Health Score pillars
Profitability 25%
65
Ford reported net income of $2.5 billion for Q1 2026, but faces significant margin headwinds in its EV segment, prompting capacity rationalization (MD&A).
Balance sheet 20%
70
Total equity attributable to Ford increased to $37.5 billion, and the company completed a 26.55 million share anti-dilutive repurchase program, though full debt and cash details were omitted from the text (MD&A).
Cash generation 20%
55
While Ford distributed $0.9 billion to shareholders, upcoming cash expenditures of up to $4 billion for EV rationalization and $500 million for the BOSK transaction will pressure future cash flows (MD&A / Risk Factors).
Risk flags 20%
50
The company faces up to $4 billion in EV restructuring charges, $3.5 billion in BOSK JV termination charges, and potential collateral requirements exceeding $1 billion for Brazilian tax disputes (Risk Factors / Legal Proceedings).
Mgmt signal 15%
60
Management is aggressively pivoting away from unprofitable EV lines to address market dynamics, and the CEO/CFO certified that disclosure controls remain effective (Risk Factors / Item 4).
Key metrics (Three Months Ended March 31, 2026)
revenue: Not disclosed in the provided text
cash and equivalents: Not disclosed in the provided text
total debt: Not disclosed in the provided text
shares outstanding: Not disclosed in the provided text
net income: $2.5 billion
period: Three Months Ended March 31, 2026
operating cash flow: Not disclosed in the provided text
Gemma triage notes (pre-analysis, second opinion)
None for this filing.Automated research summaries derived from SEC filings. Not investment advice.